A full introduction to Enasidenib (ensidipine), learn about this new drug!

Enasidenib is an innovative targeted drug specifically used to treat acute myeloid leukemia (AML), especially for patients who carry IDH2 (isocitrate dehydrogenase 2) gene mutations. IDH2 mutation is one of the common driver mutations in AML, which can lead to abnormal metabolic processes and blockage of cell differentiation, thereby promoting the development of leukemia.

The working mechanism of ensidipine is to restore normal metabolic function by inhibiting IDH2 mutated isocitrate dehydrogenase activity, thereby promoting the normal differentiation of leukemia cells. Unlike traditional chemotherapy, ensidipine is an oral targeted therapy drug that does not rely on the cytotoxic effects of chemotherapy drugs. Instead, it helps leukemia cells in the body restore differentiation and function by restoring normal metabolic pathways in cells.

Clinical trials have shown that ensidipine can effectively induce remission in acute myeloid leukemia, especially in patients with IDH2 mutations. Ensidipine offers a new treatment option for older patients who cannot tolerate traditional chemotherapy or for patients with multiple relapses of leukemia. It can significantly improve patients' survival and quality of life.

However, although ensidipine brings hope to patients with acute myeloid leukemia, some patients may develop drug resistance, resulting in reduced efficacy of treatment. In addition, the use of ensidipine may be associated with some side effects, such as abnormal liver function, loss of appetite, nausea, etc. Therefore, regular monitoring and adjustments are required during treatment with ensidipine.

In general, ensidipine is a very promising new drug that effectively treats acute myeloid leukemia by targetingIDH2 mutations, especially providing new treatment opportunities for patients who are ineffective with traditional treatments. Despite this, patients still need to use drugs rationally under the guidance of a doctor, and regularly evaluate the treatment effects and side effects to ensure the best treatment effect.

Reference materials:https://www.idhifa.com/